Premium
Treatment of Infantile Cystic Acne with Oral Isotretinoin: A Case Report
Author(s) -
Arbegast Kay D.,
Braddock Suzanne W.,
Lamberty Leland F.,
Sawka Alisa R.
Publication year - 1991
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.1991.tb00311.x
Subject(s) - medicine , isotretinoin , acne , etiology , dermatology , pediatrics , antibiotics , microbiology and biotechnology , biology
Infantile cystic acne is rare, and its etiology is not clearly defined. Our patient had comedones at 2 months of age that were recalcitrant to multiple‐antibiotic regimens. His condition worsened, and he was diagnosed with infantile cystic acne at 10 months of age and started on a trial of oral isotretinoin (Accutane). A five‐month treatment period using doses ranging from 0.36 to 0.67 mg/kg was necessary to achieve adequate control. Oral isotretinoin may be safe and effective in cases of recalcitrant infantile acne, but we advocate close monitoring because of the well‐known side effects of oral retinoids.